首页 国际期刊 医学期刊 期刊详情(非官网)
400-808-1701

Vaccines

Vaccines杂志,由MDPI (Basel, Switzerland)出版,于2013年创刊,4 issues/year,出版语言English,ISSN:2076-393X,E-ISSN:2076-393X。

投稿咨询
Vaccines
Vaccines
Vaccines
SCI SCIE

杂志介绍

JCR分区
Q2
中科院分区
3区
影响因子
3.5
CiteScore
7.7
期刊收录
SCI、SCIE

Vaccines(中文译名:《疫苗》),ISSN:2076-393X,EISSN:2076-393X,是MDPI (Basel, Switzerland)出版的国际性学术期刊,创刊于2013年,以4 issues/year形式稳定发行,2026年总发文量约1269篇。该刊采用OA开放访问,学科归属为Pharmacology, Toxicology and Pharmaceutics - Pharmacology。该刊是医学、免疫学领域的国际权威刊物,已被SCI(科学引文索引)、SCIE(科学引文索引扩展版)等国际主流学术数据库收录。2026年期刊影响因子达3.5,2025年期刊CiteScore为7.7,2025年期刊自引率约8.6%,在中科院期刊分区体系中位列医学大类3区,在所属学科领域具备高学术影响力与国际认可度。Vaccines长期聚焦医学、免疫学及相关产业的技术应用前沿,平均审稿周期11 Weeks,审稿流程高效稳定。在稿件录用评判中,该刊将创新性与前沿性作为核心遴选标准,重点收录能够对医学、免疫学领域的落地与发展产生实质性推动价值的研究成果。

从全球发文格局来看,USAItaly、CHINA MAINLAND、England、Spain、France、GERMANY (FED REP GER)等为核心发文国家与地区;CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS (CSIC)UNIVERSITY OF OXFORD、UNIVERSITY OF FLORENCE、INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM)、UNIVERSITY SYSTEM OF GEORGIA、INRAE、CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS)等高校与科研机构是期刊的主要发文单位。

期刊评价

名词解释:

影响因子(Impact Factor, IF):指该期刊前两年发表的文章,在第三年的平均被引用次数。它反映了期刊的近期平均影响力和热度。

中科院分区:中科院分区表是国内主流的学术期刊分级评价工具,核心意义是建立跨学科可比的统一评价标尺,为职称评审、学位授予、科研立项等科研管理工作提供标准化量化依据,同时帮助科研人员筛选优质期刊、规避学术风险,适配国内本土化的科研评价需求。

期刊分区表

《新锐期刊分区表》(2026年3月发布)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
3区 3区

期刊分区表(2025年3月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
3区 3区

期刊分区表(2023年12月升级版)

大类学科 小类学科 Top期刊 综述期刊
医学
3区
IMMUNOLOGY 免疫学 MEDICINE, RESEARCH & EXPERIMENTAL 医学:研究与实验
3区 3区

JCR分区

2025-2026年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q2 89 / 183

51.6

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 82 / 191

57.3

学科:IMMUNOLOGY SCIE Q2 86 / 183

53.28

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q2 78 / 191

59.42

2023-2024年最新版

按JCI指标学科分区 收录子集 分区 排名 百分位
学科:IMMUNOLOGY SCIE Q1 45 / 181

75.4

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 39 / 189

79.6

学科:IMMUNOLOGY SCIE Q1 33 / 181

82.04

学科:MEDICINE, RESEARCH & EXPERIMENTAL SCIE Q1 36 / 189

81.22


中国学者近期发文

1
Fine-Mapping and Protective Analysis of Immunodominant Linear B-Cell Epitopes of FimA Antigen of Klebsiella Pneumonia

Author:Yan, Pengju; Chen, Longlong; Ming, Guangyang; Chen, Zhifu; Gou, Qiang; Yuan, Yue; Jing, Haiming; Luo, Ping; Zhang, Jinyong; Zhao, Zhuo

Journal: VACCINES. 2026; Vol. 14, Issue 4, pp. -. DOI: 10.3390/vaccines14040347

2
Virus-like and Virus Replicon Particles Targeting Multiple B-Cell Antigens Do Not Protect Against African Swine Fever Viru

Author:Lotonin, Kirill; Garcia-Nicolas, Obdulio; Kilb, Normann; Kramer, Stefan; Chang, Xinyue; Engeroff, Paul; Mehinagic, Kemal; Donze, Noelle; Brito, Francisco; Liniger, Matthias; Lieknina, Ilva; Cernova, Darja; Balta, Ieva; Gonzalez-Garcia, Gabriela; Rueda, Paloma; Zimmer, Gert; Benarafa, Charaf; Ruggli, Nicolas; Roth, Gunter; Tars, Kaspars; Bachmann, Martin; Summerfield, Artur

Journal: VACCINES. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.3390/vaccines14030285

3
Oropouche Virus (OROV) Vaccine Development for Vulnerable Populations: Epidemiological Context, Challenges and Future Direction

Author:Wu, Wenrui; Kam, Yiu-Wing

Journal: VACCINES. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.3390/vaccines14030267

4
A Comparative Review of Veterinary and Human Vaccine Development Strategies: Insights into Herpesvirus Vaccinology from Latency to Eliminatio

Author:Liu, Guangyi; Zhao, Xiaoyang; Lin, Yuezhi; Wang, Xiaojun; Liu, Diqiu

Journal: VACCINES. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.3390/vaccines14030249

5
Real-World Vaccination Data Analysis for Three Vaccines Among Individuals Aged 60 and Older in Shanghai, Chin

Author:Li, Juan; Lin, Mingzhu; Feng, Yong; Cheng, Wanran; Zhou, Cuiping; Xiao, Shaotan; Deng, Pengfei; Yang, Laibao

Journal: VACCINES. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.3390/vaccines14030246

6
Effectiveness of Influenza Vaccine in Wuhan, China During the 2024-2025 Season: A Test-Negative Case-Control Stud

Author:Zhang, Pei; Yang, Xiaokun; Chen, Banghua

Journal: VACCINES. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.3390/vaccines14030243

7
Safety of Sabin-Strain Inactivated Poliovirus Vaccine Administered Alone or Concomitantly with Other Vaccines: A Population-Based Post-Marketing Surveillance Stud

Author:Chang, Lin; Liu, Yuxi; Ren, Yuan; Li, Jing; Fang, Xing; Li, Yurong

Journal: VACCINES. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.3390/vaccines14030241

8
Preparation and Immunogenicity Prediction of Brucella melitensis mRNA Vaccine Candidate Based on omp16 and omp19 Gene

Author:Zhang, Jingjie; Borijihan, Haiyan; Chen, Yixuan; Baigude, Huricha; Bao, Lili; Quan, Fu; Yang, Dezhi

Journal: VACCINES. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.3390/vaccines14030240

9
A Precision-Engineered DC-Targeting mRNA-LNP Neoantigen Vaccine Elicits Stronger T Cell Responses and Exhibits Superior Tumor Contro

Author:Liu, Qi; Liu, Yan; Li, Jinwei; Huang, Si; Chen, Zhiying; Li, Jia; Wang, Tao; Zhou, Peipei; Huo, Jiandong; Li, Dehua

Journal: VACCINES. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.3390/vaccines14030239

10
Biosynthesis and Immunological Evaluation of a Dual-Antigen Nanoconjugate Vaccine Targeting Group A Streptococcu

Author:Li, Xiaoxia; Wang, Xiang; Kong, Decong; Jiang, Hua; Chen, Ying; Huang, Wenhua; Jiang, Yongqiang

Journal: VACCINES. 2026; Vol. 14, Issue 3, pp. -. DOI: 10.3390/vaccines14030237


在线咨询

Vaccines

国际简称:VACCINES-BASEL参考译名:疫苗

年发文量:1269 CiteScore:7.7 是否预警:否 Gold OA文章占比:100.00% 研究类文章占比:75.57%

杂志社联系方式:ST ALBAN-ANLAGE 66, BASEL, SWITZERLAND, CH-4052

Vaccines